| Product Name | MF | CAS | Details |
|---|
| 5-Bromo-1,3-dioxaindane-4-carboxylic acid | C8H5BrO4 | 72744-56-0 | Details |
| 5,5-Dimethyloxolane-3-thiol | C6H12OS | 1935942-49-6 | Details |
| Finasteride acetate | C25H40N2O4 | 222989-99-3 | Details |
| 4,5-Difluoro-1H-indole-2-carboxylic acid | C9H5F2NO2 | 884494-61-5 | Details |
| 4-(2-Methylbut-3-yn-2-yl)morpholine | C9H15NO | 7471-07-0 | Details |
| 3-Methyl-4-nitrobenzonitrile | C8H6N2O2 | 96784-54-2 | Details |
| 2-(3-Methoxyphenyl)propan-2-amine hydrochloride | C10H16ClNO | 1322200-79-2 | Details |
| (2-Chloro-3-hydroxyphenyl)boronic acid | C6H6BClO3 | 854778-29-3 | Details |
| Trifluoromethylphosphonic Acid | CH2F3O3P | 374-09-4 | Details |
| Methyl({2-[methyl(2,2,2-trifluoroethyl)amino]ethyl})amine | C6H13F3N2 | 1096348-60-5 | Details |
| Olmesartan N2-glucuronide | C30H34N6O9 | 369395-57-3 | Details |
| 3-(Alpha-(4-allyl-2,5-dimethyl-1-piperazinyl)-3-hydroxybenzyl)-N-(3-fluorophenyl)-N-methylbenzamide | C30H34FN3O2 | 182417-73-8 | Details |
| 4-(3-Ethyl-1,2,4-oxadiazol-5-yl)cyclohexan-1-amine hydrochloride | C10H18ClN3O | 1803610-31-2 | Details |
| Difloomotecan | C21H16F2N2O4 | 220997-97-7 | Details |
| tert-Butyl3-bromo-1H-pyrrole-1-carboxylate | C9H12BrNO2 | 475561-75-2 | Details |
| SMG5 Blocking Peptide | Details |
| H-Cys-Asp-Pro-Gly-Tyr-Ile-Gly-Ser-Arg-NH2 | C40H63N13O13S | 110590-61-9 | Details |
| 2-Picenecarboxylic acid | C28H36O5 | 118172-80-8 | Details |
| 1-(4-Cyanophenyl)cyclopentane-1-carboxylic acid | C13H13NO2 | 135569-29-8 | Details |
| Glimepiride EP Impurity J hydrochloride | Details |
| NRC-2694 | C24H26N4O3 | 936446-61-6 | Details |
| Japonicone D | C34H44O9 | 1078711-42-8 | Details |
| 5-(Piperidin-3-yl)-4-(propan-2-yl)-4H-1,2,4-triazole-3-thiol hydrochloride | C10H19ClN4S | 1269152-36-4 | Details |
| 3-(2H-1,2,3-Benzotriazol-2-yl)-5-(2,2,2-trifluoroethoxy)aniline | C14H11F3N4O | 861412-93-3 | Details |
| Octamethyl-1,7-tetrasiloxanediol | C8H26O5Si4 | 3081-07-0 | Details |
| 3-(3,5-Difluoro-2-methoxyphenyl)propionic acid | C10H10F2O3 | 1092460-64-4 | Details |
| 7-Chloro-2-hydrazinyl-3-methylquinoline | C10H10ClN3 | 1017360-44-9 | Details |
| 4-(Propane-2-sulfonyl)aniline | C9H13NO2S | 25355-76-4 | Details |
| 1-Bromo-4-[(2-chloroethyl)sulfanyl]benzene | C8H8BrClS | 16181-14-9 | Details |
| 1-(Imidazolidin-1-yl)propan-1-one | C6H12N2O | 1198795-15-1 | Details |
| H-RPQVPLRPM-OH | Details |
| p-(Trifluoromethoxy)benzonitrile | C8H4F3NO | 332-25-2 | Details |
| 1-Azido-2-iodobenzene, 1M solution in MTBE | C6H4IN3 | 54467-95-7 | Details |
| (2S)-2-Amino-3-(oxan-4-yl)propanoic acid hydrochloride | C8H16ClNO3 | 2007919-56-2 | Details |
| 1,2,3,4-Tetrahydronaphthalene-1-carbaldehyde | C11H12O | 18278-24-5 | Details |
| 2-(1-Methyl-1H-pyrazol-4-yl)ethan-1-amine dihydrochloride | C6H13Cl2N3 | 1431962-30-9 | Details |
| 1-(4-Nitrophenyl)-1H-pyrrole-2-carboxylic acid | C11H8N2O4 | 82552-86-1 | Details |
| Trypsin-Modulating Oostatic Factor (Neobelliera bullata) | C29H46N10O10 | 154277-65-3 | Details |
| (R)-Pulegone - 90% | C10H16O | 89-82-7 | Details |
| 2-Amino-3-nitrobenzaldehyde | C7H6N2O3 | 97271-97-1 | Details |
| Methyl 2-amino-5-{[(tert-butoxy)carbonyl](methyl)amino}benzoate | 2375260-73-2 | Details |
| 2,4-Diethoxybenzoic acid | C11H14O4 | 19074-30-7 | Details |
| Methyl 2-amino-2-(1-methyl-1H-pyrazol-3-yl)acetate hydrochloride | C7H12ClN3O2 | 1796890-20-4 | Details |
| N4-Benzoyl-2'-O-tert-butyldimethylsilyl-5'-O-DMT-2'C-methylcytidine 3'-CE phosphoramidite | Details |
| 3,3-Dimethylcyclopentane-1-carboxylic acid | C8H14O2 | 69393-30-2 | Details |
| 6-Chloro-1,3-dimethyl-1H-pyrazolo[3,4-b]pyridine-5-carboxaldehyde | C9H8ClN3O | 898911-34-7 | Details |
| 2-(3-Chloronaphthalen-1-yl)acetic acid | C12H9ClO2 | 58926-36-6 | Details |
| N-(4-iodophenyl)cyclopropanecarboxamide | C10H10INO | 23779-17-1 | Details |
| 2-[(2,4-Dioxo-1,2,3,4-tetrahydropyrimidin-5-yl)formamido]acetic acid | C7H7N3O5 | 89937-94-0 | Details |
| 1-[4-(1-Aminoethyl)phenyl]-3-cyclopropylurea | C12H17N3O | 1250659-48-3 | Details |
| (5S)-9-Fluoro-2,3,4,5-tetrahydro-1-benzoxepin-5-ol | C10H11FO2 | 1568193-23-6 | Details |
| 3-((Trimethylsilyl)ethynyl)pyridine-2-carbaldehyde | C11H13NOSi | 222168-23-2 | Details |
| 5-[(Methylamino)methyl]-2,3-dihydro-1,3,4-oxadiazol-2-one hydrochloride | C4H8ClN3O2 | 1046079-42-8 | Details |
| EFNA2 Blocking Peptide | Details |
| 2-(Cyclopentylmethyl)oxirane | C8H14O | 104727-79-9 | Details |
| 2-(4-(tert-Butyl)phenoxy)pyridine-3-carboxylic acid | C16H17NO3 | 54659-69-7 | Details |
| N-(2-Chloro-5-nitrophenyl)cyclohexylformamide | C13H15ClN2O3 | 544701-14-6 | Details |
| Z-Homoarg (Pbf)-OH | C28H38N4O7S | 1313054-85-1 | Details |
| FNDC4 Blocking Peptide | Details |
| APPL1 Blocking Peptide | Details |
| 3-Methyl-2-(pyridin-3-yl)butanoic acid | C10H13NO2 | 699527-72-5 | Details |
| Sucrose dipalmitate | C44H82O13 | 248917-86-4 | Details |
| 5-Chloro-2-methoxybenzenethiol | C7H7ClOS | 768-13-8 | Details |
| 2-(Dimethylamino)-2-(1H-pyrrol-2-yl)acetonitrile | C8H11N3 | 117067-98-8 | Details |
| FGF19 protein | Details |
| 3,3-Difluoro-1-(1H-triazol-5-yl)cyclobutanamine dihydrochloride | C6H8F2N4.2ClH | 2316459-16-0 | Details |
| MED4 protein (His tag) | Details |
| NEIL2 antibody | Details |
| 4-Bromo-7-methoxy-1,2-dihydroisoquinolin-1-one | C10H8BrNO2 | 1207448-48-3 | Details |
| tert-Butyl N-(4-aminobutan-2-yl)-N-methylcarbamate | C10H22N2O2 | 1311317-84-6 | Details |
| H-KLPQLCTEL-OH | Details |
| Ethyl 5-ethyl-1,3,4-thiadiazole-2-carboxylate | C7H10N2O2S | 1330751-86-4 | Details |
| 2-(2,6-Dimethylmorpholin-4-yl)ethanamine | C8H18N2O | 244789-18-2 | Details |
| 2,5-Bis(propan-2-yl)benzene-1-sulfonyl chloride | C12H17ClO2S | 61942-72-1 | Details |
| 3-Fluoro-5-iodobenzotrifluoride | C7H3F4I | 1027513-14-9 | Details |
| [(3-Bromophenyl)methyl]hydrazine hydrochloride | C7H10BrClN2 | 1384427-52-4 | Details |
| 4-(Hexyloxy)-3-methoxybenzaldehyde | C14H20O3 | 61096-84-2 | Details |
| 4-[(1-Methyl-1H-pyrazol-4-yl)amino]pyridine-3-carboxylic acid | C10H10N4O2 | 1539209-73-8 | Details |
| 2,3-Dihydro-2,2-dimethyl-7-nitrobenzofuran | C10H11NO3 | 13414-55-6 | Details |
| VEGFC protein (Rat) | Details |
| TSH Receptor Antibody Positive Human Plasma | Details |
| N-[(4-methoxyphenyl)methyl]-1-phenylcyclopentane-1-carboxamide | C20H23NO2 | 864383-74-4 | Details |
| 4-[(Methylcarbamoyl)amino]benzoic acid | C9H10N2O3 | 54057-66-8 | Details |
| ALX3 Blocking Peptide | Details |
| H-AHVQVVDSNGNR-OH | Details |
| [4-(4-Methylphenyl)oxan-4-yl]methanamine hydrochloride | C13H20ClNO | 1311314-11-0 | Details |
| Aldol??515 palmitate, Biosynth Patent: EP 2427431 and US 8940909 | C39H50N2O3 | 2484872-73-1 | Details |
| Thiophene-3-sulfonamide | C4H5NO2S2 | 64255-63-6 | Details |
| NKRF antibody | Details |
| Aldol??518 myo-inositol-1-phosphate - Biosynth Patent: EP 2427431 and US 8940909 | C29H30ClN2O10P | 2484873-17-6 | Details |
| 4-N-Pentyl-d11-phenol | C11H16O | 1219805-30-7 | Details |
| 2-(4-Methoxyphenyl)-1-methyl-6-oxopiperidine-3-carboxylic acid | C14H17NO4 | 75810-44-5 | Details |
| 3,3-Difluorobutan-1-ol | C4H8F2O | 858359-36-1 | Details |
| (±)-1-(4-Bromophenyl)ethyl isocyanate | C9H8BrNO | 207974-15-0 | Details |
| N-(6-Phenyl-2,3-dihydro-1H-inden-1-ylidene)hydroxylamine | C15H13NO | 1807938-00-6 | Details |
| GCH1 Blocking Peptide | Details |
| H-PFRLMHPQPEDPD-OH | Details |
| Etifoxine-d3 | C17H14ClD3N2O | 1246815-89-3 | Details |
| 3-(4-Chloro-phenyl)-4,5-dihydro-isoxazole-5-carboxylic acid | C10H8ClNO3 | 109888-59-7 | Details |
| Aldol??515 L-pyroglutamic acid amide, Biosynth Patent: EP 2427431 and US 8940909 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||